Source: PRWeb

Press Release: COPAN : Copan Colibr Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities

MURRIETA, Calif., Jan. 29, 2024 /PRNewswire/ -- Copan Diagnostics, a leader in Clinical Microbiology automation solutions, has announced the third FDA clearance for its innovative pre-analytical processor, Colibrí . The automated ID/AST preparation instrument is a key component in Copan's...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Fabrizio Mazzocchi's photo - CEO of COPAN

CEO

Fabrizio Mazzocchi

CEO Approval Rating

90/100

Read more